Clinical utility of the SPISE index as an indicator of insulin resistance in pediatric obesity
Öz
Purpose: Single Point Insulin Sensitivity Estimator (SPISE) index is a lipid-based marker of insulin sensitivity, but data on its role in pediatric obesity are limited. This study evaluated its performance in identifying metabolic syndrome (MetS) and related metabolic risk factors in children and adolescents with obesity.
Materials and Methods: In this retrospective study, anthropometric and laboratory data were collected, and the SPISE index was calculated based on BMI, triglyceride, and HDL cholesterol levels. Correlation analyses and receiver operating characteristic (ROC) analyses were performed to assess the association of SPISE with metabolic parameters and its performance, compared with HOMA-IR, in detecting MetS.
Results: A total of 213 participants (58.7% female) with a mean age of 12.6 ± 3.2 years were included. The SPISE index showed inverse correlations with BMI SDS (r = −0.714), TG/HDL ratio (r = −0.559), TyG index (r = −0.457), HOMA-IR (r = −0.395), and age (r = −0.327). Lower SPISE values were observed in participants with severe obesity, elevated HOMA-IR, hepatic steatosis, hypertension, and metabolic syndrome. For the detection of MetS, the SPISE index demonstrated an AUC of 0.833 (95% CI: 0.767–0.886), with 96.7% sensitivity and 62.0% specificity at a cut-off value of <5.09, whereas HOMA-IR showed an AUC of 0.709.
Conclusion: The SPISE index appears to be a practical and reliable insulin-independent marker associated with metabolic risk in pediatric obesity and may represent a useful screening tool for identifying children and adolescents at risk for metabolic syndrome.
Anahtar Kelimeler
SPISE index, pediatric obesity, insulin resistance, metabolic syndrome, HOMA-IR
Proje Numarası
(Approval No: 1144, Date: 19.02.2026).
Kaynakça
- Zhang X, Liu Y, Wang J, Chen L, Smith T, Rodriguez A, et al. Global prevalence of overweight and obesity in children and adolescents: a systematic review and meta-analysis. JAMA Pediatr. 2024;178:800-13.
- Barutcu A, Ornek C, Kozanoglu E. A growing problem in childhood and adolescence: Metabolic syndrome and its relationship with physical activity and fitness. Marmara Med J. 2023;36:255-61.
- 3.Zhang B, Shi H, Cai W, Yang B, Xiu W. Metabolic syndrome in children and adolescents: definitions, epidemiology, pathophysiology, interventions, and challenges. Front Endocrinol (Lausanne). 2025;16:1512642.
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-19.
- Hellman B. Pulsatility of insulin release–a clinically important phenomenon. Ups J Med Sci. 2009;114:193-205.
- Abacı A, Hızlı Ş, Özdemir O, Razi CH, Koçak M, Akın O et al. Obez çocuklarda serum magnezyum düzeyinin insülin direnci ile olan ilişkisi. Güncel Pediatri. 2010;8:24–29.
- Kalyoncu D, Kavrak Kursun M. Comparison of triglyceride glucose index and other insulin resistance indexes in children with overweight and obesity. BMC Endocr Disord. 2025;25:96.
- Di Bonito P, Moio N, Scilla C, Cavuto L, Sibilio G, Sanguigno E et al. Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Diabetes Care. 2012;35:158-62.
- Brito ADM, Hermsdorff HHM, Filgueiras MS, Suhett LG, Vieira-Ribeiro SA, Franceschini SDCCet al. Predictive capacity of triglyceride-glucose (TyG) index for insulin resistance and cardiometabolic risk in children and adolescents: a systematic review. Crit Rev Food Sci Nutr. 2021;61:2783-92.
- Paulmichl K, Hatunic M, Højlund K, Jotic A, Krebs M, Mitrakou A et al. Modification and validation of the triglyceride-to-HDL cholesterol ratio as a surrogate of insulin sensitivity in white juveniles and adults without diabetes mellitus: the single point insulin sensitivity estimator (SPISE). Clin Chem. 2016;62:1211-19.
